Insider Transactions last 24 months for Arcus Biosciences, Inc.  -  NYSE: RCUS

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Azoy AlexanderChief Accounting Officer09/05/2025DSDirectCOM1,579$11.88$18,758.0530,194
Lambert NicoleDirector06/10/2025AADirectCOM13,300$0.00$0.0037,300
Kaneko YasunoriDirector06/10/2025AADirectCOM13,300$0.00$0.0033,300
Lacey David L.Director06/10/2025AADirectCOM13,300$0.00$0.0070,952
Ribas AntoniDirector06/10/2025AADirectCOM13,300$0.00$0.0043,650
Machado PatrickDirector06/10/2025AADirectCOM13,300$0.00$0.0038,600
Falberg Kathryn EDirector06/10/2025AADirectCOM13,300$0.00$0.0068,600
Perlman Andrew JDirector06/10/2025AADirectCOM13,300$0.00$0.0042,625
Rosen Terry JChief Executive Officer02/27/2025APDirectCOM19,800$10.18$201,465.002,554,160
Kaneko YasunoriDirector02/27/2025APDirectCOM20,000$10.06$201,200.0028,400
Gilead Sciences, Inc.Other02/18/2025APDirectCOM1,363,636$11.00$14,999,996.0031,424,760
Markus RichardChief Medical Officer02/10/2025AADirectCOM75,193$0.00$0.0075,193
Jaen Juan C.President01/23/2025AADirectCOM50,000$0.00$0.00367,220
Azoy AlexanderChief Accounting Officer01/23/2025AADirectCOM17,100$0.00$0.0030,194
Goeltz Ii Robert C.Chief Financial Officer01/23/2025AADirectCOM37,000$0.00$0.0097,138
Jarrett JenniferChief Operating Officer01/23/2025AADirectCOM50,000$0.00$0.00213,369
Rosen Terry JChief Executive Officer01/23/2025AADirectCOM165,000$0.00$0.002,534,360
Tang Carolyn C.General Counsel01/23/2025AADirectCOM37,000$0.00$0.00137,623
Goeltz Ii Robert C.Chief Financial Officer12/31/2024DSDirectCOM3,594$15.00$53,910.0060,138
Azoy AlexanderChief Accounting Officer12/19/2024DDDirectCOM3,007$15.17$45,616.1913,094
Jaen Juan C.President12/15/2024DFDirectCOM17,286$16.08$277,958.88317,220
Azoy AlexanderChief Accounting Officer12/15/2024DFDirectCOM2,969$16.08$47,741.5216,101
Goeltz Ii Robert C.Chief Financial Officer12/15/2024DFDirectCOM10,099$16.08$162,391.9263,732
Nuyten Dimitry SaChief Medical Officer12/15/2024DFDirectCOM7,856$16.08$126,324.4887,518
Rosen Terry JChief Executive Officer12/15/2024DFDirectCOM37,882$16.08$609,142.562,369,360
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel